Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Commission weighs fentanyl‑related enhancements and scope of fentanyl‑related substances
Summary
DOJ urged strong, offense‑based enhancements for fentanyl, adulterants (xylazine) and pill presses; defenders and public‑health commentators urged careful targeting, more public‑health input, and worry that some proposed enhancements would be duplicative or lack empirical evidence of reducing harm.
Department of Justice witnesses urged the commission to adopt robust enhancements for fentanyl, fentanyl analogs, and fentanyl‑related substances (FRS), including offense‑based enhancements for distribution to minors, adulterants such as xylazine, pill presses, and dark‑web trafficking. DOJ speakers said these enhancements reflect the exceptional danger of fentanyl and operational challenges for investigators.
Caitlin (DOJ acting narcotics chief) and other DOJ…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
